{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T23:21:08Z","timestamp":1794612068886,"version":"4.9.1"},"reference-count":18,"publisher":"Oxford University Press (OUP)","issue":"5","license":[{"start":{"date-parts":[[2023,5,2]],"date-time":"2023-05-02T00:00:00Z","timestamp":1682985600000},"content-version":"vor","delay-in-days":1,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,5,3]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Diabetic foot infections (DFIs) are frequently polymicrobial, yet the relevance of each isolated pathogen, remains ill-defined. Specifically, the prevalence and pathogenicity of enterococcal DFIs and the impact of targeted antienterococcal treatment remain elusive.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We collected demographic, clinical, and outcome-related data on patients admitted with DFIs to the Hadassah Medical Center diabetic foot unit between 2014 and 2019. The primary outcome was a composite of in-hospital death or major amputation. Secondary outcomes included any amputation, major amputation, length of stay (LOS), and 1-year major amputation or mortality rate.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Enterococci were isolated in 35% of 537 eligible DFI case patients, who were notable for a higher prevalence of peripheral vascular disease, increased levels of C-reactive protein, and higher Wagner scores. Infection in enterococci-positive individuals was mostly polymicrobial (96.8% vs 61.0% in non\u2013enterococci-infected patients; P &amp;lt; .001). Enterococci-infected patients were more likely to undergo amputation (72.3% vs 50.1%; P &amp;lt; .001) and had longer hospital stays (median LOS, 22.5 vs 17\u2005days; P &amp;lt; .001), but the primary end point of major amputation or in-hospital death did not differ between groups (25.5% vs 21.0%; P = .26). Appropriate antienterococcal antibiotics were used in 78.1% of enterococci-infected patients and, compared with results in untreated patients, were associated with a trend toward a lower rate of major amputations (20.4% vs 34.1%; P = .06) but longer hospitalization (median LOS, 24 vs 18\u2005days; P = .07).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Enterococci are common in DFIs and associated with higher rates of amputation and longer hospitalization. A reduction in major amputation rates with appropriate enterococci treatment is suggested retrospectively, meriting validation by future prospective studies.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/ofid\/ofad238","type":"journal-article","created":{"date-parts":[[2023,5,2]],"date-time":"2023-05-02T16:43:38Z","timestamp":1683045818000},"source":"Crossref","is-referenced-by-count":14,"title":["Enterococci in Diabetic Foot Infections: Prevalence, Clinical Characteristics, and Outcomes"],"prefix":"10.1093","volume":"10","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9402-9039","authenticated-orcid":false,"given":"Ofer","family":"Perzon","sequence":"first","affiliation":[{"name":"Department of Internal Medicine, Hadassah Hebrew University Medical Center , Ein Kerem, Jerusalem , Israel"},{"name":"Faculty of Medicine, Hebrew University of Jerusalem , Jerusalem , Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7830-9994","authenticated-orcid":false,"given":"Avivit","family":"Cahn","sequence":"additional","affiliation":[{"name":"Diabetes Unit, Department of Endocrinology and Metabolism, Hadassah Hebrew University Medical Center , Ein Kerem, Jerusalem , Israel"},{"name":"Faculty of Medicine, Hebrew University of Jerusalem , Jerusalem , Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yechiel N","family":"Gellman","sequence":"additional","affiliation":[{"name":"Diabetic Foot Unit, Department of Orthopedics, Hadassah Hebrew University Medical Center , Ein Kerem, Jerusalem , Israel"},{"name":"Faculty of Medicine, Hebrew University of Jerusalem , Jerusalem , Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michal","family":"Leibovitch","sequence":"additional","affiliation":[{"name":"Department of Military Medicine and \u201cTzameret,\u201d Faculty of Medicine, Hebrew University of Jerusalem , Jerusalem , Israel"},{"name":"Medical Corps, Israel Defense Forces , Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shahar","family":"Peled","sequence":"additional","affiliation":[{"name":"Department of Military Medicine and \u201cTzameret,\u201d Faculty of Medicine, Hebrew University of Jerusalem , Jerusalem , Israel"},{"name":"Medical Corps, Israel Defense Forces , Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ofer","family":"Elishoov","sequence":"additional","affiliation":[{"name":"Diabetic Foot Unit, Department of Orthopedics, Hadassah Hebrew University Medical Center , Ein Kerem, Jerusalem , Israel"},{"name":"Faculty of Medicine, Hebrew University of Jerusalem , Jerusalem , Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amir","family":"Haze","sequence":"additional","affiliation":[{"name":"Diabetic Foot Unit, Department of Orthopedics, Hadassah Hebrew University Medical Center , Ein Kerem, Jerusalem , Israel"},{"name":"Faculty of Medicine, Hebrew University of Jerusalem , Jerusalem , Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen","family":"Olshtain-Pops","sequence":"additional","affiliation":[{"name":"Department of Clinical Microbiology and Infectious diseases, Hadassah Hebrew University Medical Center , Ein Kerem, Jerusalem , Israel"},{"name":"Faculty of Medicine, Hebrew University of Jerusalem , Jerusalem , Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hila","family":"Elinav","sequence":"additional","affiliation":[{"name":"Department of Clinical Microbiology and Infectious diseases, Hadassah Hebrew University Medical Center , Ein Kerem, Jerusalem , Israel"},{"name":"Faculty of Medicine, Hebrew University of Jerusalem , Jerusalem , Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2023,5,3]]},"reference":[{"key":"2023052401072189900_ofad238-B1","doi-asserted-by":"crossref","first-page":"2367","DOI":"10.1056\/NEJMra1615439","article-title":"Diabetic foot ulcers and their recurrence","volume":"376","author":"Armstrong","year":"2017","journal-title":"N Engl J Med"},{"key":"2023052401072189900_ofad238-B2","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.diabres.2008.11.030","article-title":"Risk factors for developing osteomyelitis in patients with diabetic foot wounds","volume":"83","author":"Lavery","year":"2009","journal-title":"Diabetes Res Clin Pract"},{"issue":"suppl 1","key":"2023052401072189900_ofad238-B3","doi-asserted-by":"crossref","first-page":"e3280","DOI":"10.1002\/dmrr.3280","article-title":"Guidelines on the diagnosis and treatment of foot infection in persons with diabetes (IWGDF 2019 update)","volume":"36","author":"Lipsky","year":"2020","journal-title":"Diabetes Metab Res Rev"},{"issue":"suppl 1","key":"2023052401072189900_ofad238-B4","doi-asserted-by":"crossref","first-page":"e3273","DOI":"10.1002\/dmrr.3273","article-title":"Guidelines on the classification of diabetic foot ulcers (IWGDF 2019)","volume":"36","author":"Monteiro-Soares","year":"2020","journal-title":"Diabetes Metab Res Rev"},{"key":"2023052401072189900_ofad238-B5","doi-asserted-by":"publisher","DOI":"10.1128\/microbiolspec.GPP3-0053-2018","article-title":"Pathogenicity of enterococci","volume":"7","author":"Fiore","year":"2019","journal-title":"Microbiol Spectr"},{"key":"2023052401072189900_ofad238-B6","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1086\/498112","article-title":"Culture of percutaneous bone biopsy specimens for diagnosis of diabetic foot osteomyelitis: concordance with ulcer swab cultures","volume":"42","author":"Senneville","year":"2006","journal-title":"Clin Infect Dis"},{"key":"2023052401072189900_ofad238-B7","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1007\/s10096-015-2544-1","article-title":"The microbiome of diabetic foot osteomyelitis","volume":"35","author":"van Asten","year":"2016","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"2023052401072189900_ofad238-B8","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1007\/s12223-017-0547-2","article-title":"Severity of drug resistance and co-existence of Enterococcus faecalis in diabetic foot ulcer infections","volume":"63","author":"Shettigar","year":"2018","journal-title":"Folia Microbiol (Praha)"},{"key":"2023052401072189900_ofad238-B9","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.eimc.2015.01.007","article-title":"Characterization of multidrug-resistant diabetic foot ulcer enterococci","volume":"34","author":"Semedo-Lemsaddek","year":"2016","journal-title":"Enferm Infecc Microbiol Clin"},{"key":"2023052401072189900_ofad238-B10","doi-asserted-by":"crossref","first-page":"e132","DOI":"10.1093\/cid\/cis346","article-title":"Infectious Diseases Society of America clinical practice guideline for the diagnosis and treatment of diabetic foot infections","volume":"54","author":"Lipsky","year":"2012","journal-title":"Clin Infect Dis"},{"key":"2023052401072189900_ofad238-B11","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1016\/0002-9343(87)90894-1","article-title":"Osteomyelitis in the feet of diabetic patients: long-term results, prognostic factors, and the role of antimicrobial and surgical therapy","volume":"83","author":"Bamberger","year":"1987","journal-title":"Am J Med"},{"key":"2023052401072189900_ofad238-B12","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1093\/cid\/cir842","article-title":"Systemic antibiotic therapy for chronic osteomyelitis in adults","volume":"54","author":"Spellberg","year":"2012","journal-title":"Clin Infect Dis"},{"key":"2023052401072189900_ofad238-B13","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1111\/dom.13651","article-title":"Oral amoxicillin-clavulanate for treating diabetic foot infections","volume":"21","author":"Gariani","year":"2019","journal-title":"Diabetes Obes Metab"},{"key":"2023052401072189900_ofad238-B14","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1056\/NEJMoa1710926","article-title":"Oral versus intravenous antibiotics for bone and joint infection","volume":"380","author":"Li","year":"2019","journal-title":"N Engl J Med"},{"key":"2023052401072189900_ofad238-B15","doi-asserted-by":"crossref","first-page":"e37680","DOI":"10.5812\/pedinfect.37680","article-title":"Diabetic foot infections: antibiotic susceptibility patterns and determination of antibiotic cross-resistance in clinical isolates of Enterococcus species during 2012\u20132014 in Shiraz, Iran","volume":"5","author":"Anvarinejad M","year":"2016","journal-title":"Arch Pediat Infect Dis"},{"key":"2023052401072189900_ofad238-B16","doi-asserted-by":"crossref","first-page":"e20202471","DOI":"10.1590\/0100-6991e-20202471","article-title":"Microbiologic characteristics and antibiotic resistance rates of diabetic foot infections","volume":"47","author":"Pontes","year":"2020","journal-title":"Rev Col Bras Cir"},{"key":"2023052401072189900_ofad238-B17","doi-asserted-by":"crossref","first-page":"4305","DOI":"10.1128\/AAC.00444-09","article-title":"Pilot study of ampicillin-ceftriaxone combination for treatment of orthopedic infections due to Enterococcus faecalis","volume":"53","author":"Euba","year":"2009","journal-title":"Antimicrob Agents Chemother"},{"key":"2023052401072189900_ofad238-B18","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1086\/591536","article-title":"Outcome of enterococcal prosthetic joint infection: is combination systemic therapy superior to monotherapy?","volume":"47","author":"El Helou","year":"2008","journal-title":"Clin Infect Dis"}],"container-title":["Open Forum Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ofid\/advance-article-pdf\/doi\/10.1093\/ofid\/ofad238\/50172330\/ofad238.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ofid\/article-pdf\/10\/5\/ofad238\/50426062\/ofad238.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ofid\/article-pdf\/10\/5\/ofad238\/50426062\/ofad238.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,12,11]],"date-time":"2023-12-11T17:43:50Z","timestamp":1702316630000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ofid\/article\/doi\/10.1093\/ofid\/ofad238\/7148321"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5]]},"references-count":18,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2023,5,3]]}},"URL":"https:\/\/doi.org\/10.1093\/ofid\/ofad238","relation":{},"ISSN":["2328-8957"],"issn-type":[{"value":"2328-8957","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2023,5]]},"published":{"date-parts":[[2023,5]]},"article-number":"ofad238"}}